Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment
The liposome is the first nanomedicine transformed into the market and applied to human patients. Since then, such phospholipid bilayer vesicles have undergone technological advancements in delivering small molecular-weight compounds and biological drugs. Numerous investigations about liposome uses...
Main Authors: | Yonglong He, Wanting Zhang, Qingqing Xiao, Lifang Fan, Dechun Huang, Wei Chen, Wei He |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-11-01
|
Series: | Asian Journal of Pharmaceutical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1818087622001040 |
Similar Items
-
Liposomal Formulations in Clinical Use: An Updated Review
by: Upendra Bulbake, et al.
Published: (2017-03-01) -
Acoustically-Activated Liposomal Nanocarriers to Mitigate the Side Effects of Conventional Chemotherapy with a Focus on Emulsion-Liposomes
by: Mah Noor Zafar, et al.
Published: (2023-01-01) -
Lipid-Based Nanotechnology: Liposome
by: Yanhao Jiang, et al.
Published: (2023-12-01) -
Liposomal curcumin and its application in cancer
by: Feng T, et al.
Published: (2017-08-01) -
Nanomedicine review: clinical developments in liposomal applications
by: Esteban Beltrán-Gracia, et al.
Published: (2019-12-01)